已收盘 07-25 16:00:00 美东时间
0.000
0.00%
Yesterday Pluristem Therapeutics Inc (NASDAQ: PSTI) announced top-line results from its Phase 3 trial evaluating PLX-PAD in 240 patients for muscle recovery following hip fracture surgery.
2022-07-16 01:32
Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI) (“Pluristem” or the “Company”), a leading biotechnology company, today announced topline results from its multinational double-blind,
2022-07-13 18:02
Cullinan Oncology (NASDAQ:CGEM – Get Rating) and Pluristem Therapeutics (NASDAQ...
2022-07-12 15:31
StockNews.com initiated coverage on shares of Pluristem Therapeutics (NASDAQ:PS...
2022-07-11 16:31
Pluristem Therapeutics (NASDAQ:PSTI – Get Rating) and Cullinan Oncology (NASDAQ...
2022-07-07 14:22
StockNews.com initiated coverage on shares of Pluristem Therapeutics (NASDAQ:PS...
2022-07-06 13:51
Pluristem Therapeutics Inc. (NASDAQ:PSTI – Get Rating) saw a significant declin...
2022-07-05 21:31
北京时间2022年06月09日00时35分,Pluristem Therapeutics Inc(PSTI.us)股票出现异动,股价急速上涨11.20%。截至发...
2022-06-09 01:12
北京时间2022年04月27日01时24分,Pluristem Therapeutics Inc(PSTI.us)股票出现异动,股价急速跳水5.12%。截至发稿...
2022-04-27 02:20